Abstract
The potential tumor suppressor antizyme and its endogenous inhibitor (antizyme inhibitor, AZI) have been implicated in the ubiquitin-independent proteasomal degradation of proteins involved in cell proliferation as well as in the regulation of polyamine levels. We show here that both antizyme and AZI concentrate at centrosomes and that antizyme preferentially associates with the maternal centriole. Interestingly, alterations in the levels of these proteins have opposing effects on centrosomes. Depletion of antizyme in various cell lines and primary cells leads to centrosome overduplication, whereas overexpression of antizyme reduces numerical centrosome abnormalities. Conversely, silencing of the antizyme inhibitor, AZI, results in a decrease of numerical centrosome abnormalities, whereas overexpression of AZI leads to centrosome overduplication. We further show that the numerical centrosome abnormalities are due to daughter centriole amplification. In summary, our results demonstrate that alterations in the antizyme/AZI balance cause numerical centrosomal defects and suggest a role for ubiquitin-independent proteasomal degradation in centrosome duplication.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M . (2003). Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570–574.
Choi KS, Suh YH, Kim WH, Lee TH, Jung MH . (2005). Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity. Biochem Biophys Res Commun 328: 206–212.
Coffino P . (2001). Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2: 188–194.
D'Assoro AB, Lingle WL, Salisbury JL . (2002). Centrosome amplification and the development of cancer. Oncogene 21: 6146–6153.
Doxsey S, Zimmerman W, Mikule K . (2005). Centrosome control of the cell cycle. Trends Cell Biol 15: 303–311.
Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN . (2000). Activity and regulation of the centrosome-associated proteasome. J Biol Chem 275: 409–413.
Fong LY, Feith DJ, Pegg AE . (2003). Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res 63: 3945–3954.
Fukasawa K . (2005). Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230: 6–19.
Gerner EW, Meyskens Jr FL . (2004). Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4: 781–792.
Guarguaglini G, Duncan PI, Stierhof YD, Holmstrom T, Duensing S, Nigg EA . (2005). The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles. Mol Biol Cell 16: 1095–1107.
Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA . (2005). The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 7: 1140–1146.
Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T et al. (1999). Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene 18: 165–172.
Jung MH, Kim SC, Jeon GA, Kim SH, Kim Y, Choi KS et al. (2000). Identification of differentially expressed genes in normal and tumor human gastric tissue. Genomics 69: 281–286.
Keren-Paz A, Bercovich Z, Porat Z, Erez O, Brener O, Kahana C . (2006). Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions. Oncogene 25: 5163–5172.
Kim SW, Mangold U, Waghorne C, Mobascher A, Shantz L, Banyard J et al. (2006). Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism. J Cell Sci 119: 2583–2591.
Koike C, Chao DT, Zetter BR . (1999). Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. Cancer Res 59: 6109–6112.
Lange BM, Gull K . (1995). A molecular marker for centriole maturation in the mammalian cell cycle. J Cell Biol 130: 919–927.
Lim SK, Gopalan G . (2007). Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through an alternative ubiquitin-independent pathway. Biochem J 403: 119–127.
Lin Y, Martin J, Gruendler C, Farley J, Meng X, Li BY et al. (2002). A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). BMC Cell Biol 3: 15.
Meraldi P, Lukas J, Fry AM, Bartek J, Nigg EA . (1999). Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat Cell Biol 1: 88–93.
Meraldi P, Nigg EA . (2002). The centrosome cycle. FEBS Lett 521: 9–13.
Mitchell JL, Judd GG, Leyser A, Choe C . (1998). Osmotic stress induces variation in cellular levels of ornithine decarboxylase-antizyme. Biochem J 329: 453–459.
Murai N, Murakami Y, Matsufuji S . (2003). Identification of nuclear export signals in antizyme-1. J Biol Chem 278: 44791–44798.
Murakami Y, Ichiba T, Matsufuji S, Hayashi S . (1996). Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase. J Biol Chem 271: 3340–3342.
Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T et al. (1992). Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360: 597–599.
Nelsen CJ, Kuriyama R, Hirsch B, Negron VC, Lingle WL, Goggin MM et al. (2005). Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem 280: 768–776.
Newman RM, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M et al. (2004). Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem 279: 41504–41511.
Nigg EA . (2006). Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 119: 2717–2723.
Oredsson SM . (2003). Polyamine dependence of normal cell-cycle progression. Biochem Soc Trans 31: 366–370.
Sluder G . (2005). Two-way traffic: centrosomes and the cell cycle. Nat Rev Mol Cell Biol 6: 743–748.
Tsou MF, Stearns T . (2006). Controlling centrosome number: licenses and blocks. Curr Opin Cell Biol 18: 74–78.
Tsuji T, Usui S, Aida T, Tachikawa T, Hu GF, Sasaki A et al. (2001). Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme. Oncogene 20: 24–33.
Zou C, Li J, Bai Y, Gunning WT, Wazer DE, Band V et al. (2005). Centrobin: a novel daughter centriole-associated protein that is required for centriole duplication. J Cell Biol 171: 437–445.
Acknowledgements
We thank Senya Matsufuji (Jikei University) and John Mitchell (Northern Illinois University) for their generous gifts of mouse monoclonal AZI antibody and rabbit polyclonal antizyme 1 antibody. We also thank Sri Diah and Sonia Kim for designing the siRNAs against rodent antizyme 1 and AZI. Special thanks to Amy Baldwin for providing the HFK cells. This work was supported by Grants no. CA37393 and CA066980 from the USPHS. The authors declare that they have no commercial affiliations/conflicts of interests with regard to this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Mangold, U., Hayakawa, H., Coughlin, M. et al. Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification. Oncogene 27, 604–613 (2008). https://doi.org/10.1038/sj.onc.1210685
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210685
Keywords
This article is cited by
-
Antizyme inhibitor family: biological and translational research implications
Cell Communication and Signaling (2024)
-
A role for antizyme inhibitor in cell proliferation
Amino Acids (2015)
-
Multiple forms of mouse antizyme inhibitor 1 mRNA differentially regulated by polyamines
Amino Acids (2014)
-
Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma
Oncogene (2013)
-
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
Nature Medicine (2013)